Dermatology Research and Practice / 2016 / Article / Tab 1

Research Article

Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions

Table 1

Demographic and comorbidity details of patients.

PatientsHeight (cm)Age (yr)Body weight (kg)History of psoriasis (yr)Comorbid conditionPrevious therapy

Patient 1165.1456510Psoriatic arthritisEmollient, cyclosporine, and methotrexate
Patient 2162.6627511Type 2 diabetes with hypertensionEmollient and methotrexate
Patient 3135.1507612Interstitial lung diseaseEmollient, cyclosporine, and methotrexate
Patient 4160.0638010Alcoholic liver diseaseEmollient, cyclosporine, and methotrexate
Patient 5135.135606HypertensionEmollient and methotrexate
Patient 6170.235658HypertensionEmollient and methotrexate
Patient 7152.4596713Type 2 diabetes with hypertensionEmollient and methotrexate